Illustrative image – not actual.Cipla has plans to set up a manufacturing facility in Iran. It has signed a definitive agreement with its existing Iranian distributor.
The company will invest about Rs 225 crore over the next three years for the machinery, equipment and technical know-how, with a 75 per cent stake.
Cipla is expanding its business into other Asian countries. In June 2014, the company made its fifth acquisition deal within a year by buying 51 per cent stake in a pharmaceuticals manufacturing and distribution business in Yemen. On 17 June 2014, it acquired a 60 per cent stake in a Sri Lankan company.
Last month, Cipla signed a deal with the American company, Salix Pharmaceuticals.
